• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down1.29% Nasdaq Down3.25%

    GlaxoSmithKline plc (GSK)

    40.76 Down 0.22(0.54%) Feb 5, 4:02PM EST
    |Pre-Market : 40.00 Down 0.76 (1.86%) 5:13AM EST - Nasdaq Real Time Price
    Analyst OpinionGet Analyst Opinion for:
    Recommendation Summary*
    Mean Recommendation (this week):2.0
    Mean Recommendation (last week):2.0

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Price Target Summary
    Mean Target:47.33
    Median Target:48.00
    High Target:49.00
    Low Target:45.00
    No. of Brokers:3

    Data provided by Thomson/First Call

    Upgrades & Downgrades History
    DateResearch FirmActionFromTo
    Oct 20, 2015Credit SuisseUpgradeUnderperformNeutral
    Sep 15, 2015Exane BNP ParibasUpgradeUnderperformNeutral
    Sep 8, 2015BofA/MerrillUpgradeUnderperformNeutral
    Jun 26, 2015LiberumUpgradeSellHold
    Jun 4, 2015Morgan StanleyDowngradeOverweightEqual-Weight
    Apr 23, 2014ArgusUpgradeHoldBuy
    May 28, 2013Deutsche BankUpgradeHoldBuy
    Jan 11, 2011JefferiesUpgradeHoldBuy
    Jun 2, 2010JefferiesUpgradeHoldBuy
    Jan 13, 2010Credit SuisseDowngradeOutperformUnderperform

    More Upgrades & Downgrades for GSK

    Data provided by Briefing.com - Take a free trial
    Complete Live market analysis of the U.S. stock and bond markets, technology stocks, economic releases, earnings reports, and day trading highlights.

    Recommendation Trends
    Current MonthLast MonthTwo Months AgoThree Months Ago
    Strong Buy2211

    Data provided by Thomson/First Call

    Currency in USD.